NutraProducts Inc. (NTPR) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of NutraProducts Inc. stock $0.48, price $0.36, upside +34.6%, quality 59 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 31, 2026.
How to read this chart
60‑month range $0.0061 – $1.30 · fair‑value band $0.2890 – $0.6035 · the $0.3600 price screens below the $0.4845 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 31, 2026.
Follow NutraProducts in your weekly email
Every Wednesday you see whether NutraProducts is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
NutraProducts Inc., a contract manufacturer, engages in the production of gummy supplements. The company was formerly known as Traack Technologies Inc. and changed its name to NutraProducts Inc. in May 2025. The company is headquartered in Irving, Texas.
Stock analysis
NutraProducts Inc. (NTPR) currently trades at $0.3600, while our model-based Fair Value estimate is $0.4845, implying the stock looks roughly 26% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $1.23 per share, and 19 of the 24 models we run sit above the $0.3600 price.
Bear case: the Economic Profit group reads lowest at $0.3050, and 5 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.2890 (bear) to $0.6035 (bull), the price of $0.3600 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Consumer Defensive sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
NutraProducts Inc. reported revenue of $8.0M in FY2026 versus $4.1M in FY2023, a compound +24.5%/yr. Reported net income was $730K in FY2026.
Key figures
Market cap $7.4M Micro · EPS (TTM) $−2.78 · Net margin 9.2% · Return on assets (EBIT) 7.0% (4-year average) · Free cash flow $435K · Net cash $9.0K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (medium confidence).
What moves the price
The share trades about 72% below its 52-week high and 112% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −1% fair-value upside, at 35%, NTPR screens cheaper than that median.
Fair Value models
Bear$0.2890Fair Value $0.4845Bull$0.6035
Price $0.3600 · Upside +34.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF$0.2800$0.3800$0.700073
Growth DCF$0.2600$0.4000$0.660071
EPV$0.2100$0.2300$0.250068
All 24 models by family
DCF Models
FCF DCF$0.2800$0.3800$0.700073
Owner Earnings$0.3000$0.5700$1.0767
5Y Revenue Exit$0.3200$0.5500$1.0464
5Y EBITDA Exit$0.3700$0.6600$1.2266
5Y P/E Exit$0.4700$1.08$1.9262
10Y Revenue Exit$0.2900$0.6300$0.860061
10Y EBITDA Exit$0.3400$0.7300$1.4259
10Y P/E Exit$0.4000$0.9200$1.8055
Earnings-Based
Graham-Dodd$0.2400$1.70$2.3860
Lynch FV$0.6900$0.9800$1.2858
PEG = 1.0$0.6900$0.9800$1.2855
EPV$0.2100$0.2300$0.250068
Multiples
P/E Multiple$0.5600$0.7500$0.940063
P/S Multiple$0.4600$0.6100$0.760058
P/B Multiple$0.0200$0.0200$0.030055
EV/EBIT$0.4300$0.5700$0.710063
EV/EBITDA$0.4000$0.5400$0.670064
EV/Revenue$0.3000$0.4300$0.570051
Asset-Based
NCAV (Graham)$0.0100$0.0200$0.020053
Growth DCF
Growth DCF$0.2600$0.4000$0.660071
Rev-Margin DCF$0.3300$0.6300$1.2163
Economic Profit
Residual Income$0.1800$0.2800$0.660060
ROIC Compounder$0.2500$0.3300$0.430067
Growth Earnings
Growth-Adj P/E$0.8600$1.23$1.6065
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+61.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.5%
’23
’24
’25
’26
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+10.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+10.0%
Dividend (yield on the price)0.0%
Profit margin 2023 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 9%
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+25.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +23.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 625 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside+34.6% · Above median
Profitability
Return on assets34.5% · Top 25%
Net margin (12 months)9.2% · Top 25%
Operating margin (12 months)0.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)0.0% · Below median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/B4.08× · Priciest 25%
Price / free cash flow (fiscal year)17.1× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "NutraProducts Inc. Fair Value". https://www.fairvalue-calculator.com/stock/NTPR
Frequently asked questions
Is NutraProducts Inc. (NTPR) overvalued or undervalued?
As of Oct 31, 2026, our model estimates a fair value of $0.4845 versus a price of $0.3600, about +35% upside (undervalued).
What is the fair value of NTPR?
Our model-based fair value for NutraProducts Inc. is $0.4845 (as of Oct 31, 2026), built from audited fundamentals. The current price: $0.3600.
What is the quality score of NTPR?
NutraProducts Inc. has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NutraProducts Inc. (NTPR)?
Our model-based price target is the fair value of $0.4845 (as of Oct 31, 2026) from 24 valuation models. Cautious scenario $0.2890, optimistic scenario $0.6035. It is a calculation from audited fundamentals, not an analyst target.
What is the NutraProducts Inc. stock forecast for 2026?
Our models put fair value at $0.4845, about +35% upside versus a price of $0.3600 (undervalued). Cautious scenario $0.2890, optimistic scenario $0.6035. The calculation is refreshed regularly with new filings.
What growth is priced into NutraProducts Inc. (NTPR)?
For today's price to be fair in a discounted-cash-flow model, NutraProducts Inc. would have to grow free cash flow by +25.9 % per year for five years (discount rate 12.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +24.5 % per year. As of Oct 31, 2026.
What discount rate (WACC) does the fair value of NTPR use?
Our models discount NutraProducts Inc. at 12.2 %: a base by market capitalisation (nano), damped by beta 5.82, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For NutraProducts Inc. that is +25.9 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.2 %) and the same formula as our fair value.
How much growth has NutraProducts Inc. (NTPR) delivered so far?
Over the past 3 years revenue at NutraProducts Inc. grew +24.5 % a year. The price currently implies free-cash-flow growth of +25.9 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of NutraProducts Inc. (NTPR) growing?
The median revenue growth in the sector is +2.0 % a year. That is the yardstick for the growth priced into NutraProducts Inc. (+25.9 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of NutraProducts Inc. (NTPR)?
The free-cash-flow yield on the price is 2.89 %: that much free cash flow NutraProducts Inc. produces per unit of market value. When it exceeds the discount rate of our models (12.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of NutraProducts Inc. (NTPR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NutraProducts Inc. it is $0.4845 per share (as of Oct 31, 2026), against a price of $0.3600. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is NutraProducts Inc. stock overvalued or undervalued in 2026?
As of Oct 31, 2026, NTPR trades below its calculated fair value: price $0.3600, fair value $0.4845, a gap of about +35% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NTPR?
No. The price is what the market pays today ($0.3600); the fair value is what the company's own numbers justify ($0.4845). For NutraProducts Inc. the two are $0.1245 per share apart. That gap is exactly why we show both numbers side by side.
How much is NutraProducts Inc. worth?
The market values NutraProducts Inc. at about $7.4M (market capitalisation, as of Oct 31, 2026). Per share that is $0.3600; our models calculate a fair value of $0.4845 per share.
What do the bullish and bearish scenarios say about NTPR?
Our models span a range for NutraProducts Inc.: cautious scenario $0.2890, base $0.4845, optimistic $0.6035 per share (as of Oct 31, 2026, price $0.3600). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is NTPR from its 52-week high?
NutraProducts Inc. trades at $0.3600, about 72% below its 52-week high of $1.30 and 112% above the low of $0.1700 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4845 is for.
Which stocks are comparable to NutraProducts Inc.?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NutraProducts Inc. stock attractive at the current price?
The data as of Oct 31, 2026: price $0.3600, calculated fair value $0.4845 (+35%), Quality Score 59/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NTPR calculated?
We run NutraProducts Inc. through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $0.4845 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. NutraProducts Inc. currently trades 26% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NutraProducts Inc. (NTPR)?
The closing price on Nov 6, 2026 was $0.3600. Our model-based fair value is $0.4845, about +35% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NutraProducts Inc. right now?
The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($0.2890 to $0.6035) leaves room in how you read the outcome.
Key figures of NutraProducts Inc.
How large is the market capitalisation of NutraProducts Inc. (NTPR)?
The market capitalisation of NutraProducts Inc. is $7.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of NutraProducts Inc. (NTPR)?
Earnings per share at NutraProducts Inc. are $−2.78. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of NutraProducts Inc. (NTPR)?
The net margin of NutraProducts Inc. is 9.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of NutraProducts Inc. (NTPR)?
On an EBIT basis the return on assets of NutraProducts Inc. is 7.0% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net cash does NutraProducts Inc. (NTPR) hold?
NutraProducts Inc. holds more cash than debt, $9.0K net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch NutraProducts Inc. in the live analysis
One click puts NutraProducts Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Oct 31, 2026